Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
Stephen T. Holgate(University of Southampton), Huib A.M. Kerstjens, Giovanni Della Cioppa(Asahi Glass (Belgium)), J. Thirlwell(Novartis (United Kingdom)), А. Г. Чучалин(City Clinical Hospital), Kian Fan Chung(Imperial College London), Jean‐Louis Hébert(Centre hospitalier de l'Université Laval), Jean Bousquet(Charité - Universitätsmedizin Berlin), Helen Fox(Novartis (United Kingdom)), Jan Lötvall(University of Gothenburg), Gert Persson
Cited by 520
Related Papers
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
|European Respiratory Journal|2013|3.9k